Does Adding Daratumumab Benefit Transplant-Ineligible Myeloma Patients?

Researchers examined adding daratumumab to standard of care in newly diagnosed transplant-ineligible myeloma patients.

Source: CancerNetwork - December 5, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news